BLCO 📈 Bausch + Lomb - Overview

Bausch + Lomb Corporation is a leading eye health company with a global presence, operating in numerous countries including the United States, China, France, Japan, and the United Kingdom, among others. The company's business is organized into three distinct segments: Vision Care, Pharmaceuticals, and Surgical, each catering to different aspects of eye health. The Vision Care segment, for instance, offers a wide range of contact lenses, including daily disposable and frequently replaced options, as well as contact lens care products such as over-the-counter eye drops, eye vitamins, and mineral supplements designed to address common eye conditions like allergies, conjunctivitis, and dry eye.

The Pharmaceuticals segment is another key area of focus for Bausch + Lomb, with a portfolio of proprietary and generic pharmaceutical products aimed at treating various eye-related conditions, including glaucoma, eye inflammation, ocular hypertension, and retinal diseases. These products are often used in post-operative treatments, highlighting the company's commitment to supporting patients throughout their entire eye care journey. Furthermore, the company's Pharmaceuticals segment plays a critical role in addressing the growing need for effective treatments for eye diseases, which are increasingly prevalent due to factors such as aging populations and lifestyle changes.

In the Surgical segment, Bausch + Lomb provides medical device equipment, consumables, and technologies used in the treatment of cataracts, corneal, vitreous, and retinal eye conditions. This includes intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices specifically designed for cataract surgery. The company's products and services are sold through a combination of direct sales forces and independent distributors, allowing it to reach a broad customer base and provide support to eye care professionals worldwide. With a rich history dating back to 1853, Bausch + Lomb Corporation is headquartered in Vaughan, Canada, and operates as a subsidiary of Bausch Health Companies Inc.

As a global leader in the eye health industry, Bausch + Lomb Corporation is committed to innovation and customer satisfaction, with a strong online presence and a website that provides detailed information on its products and services. The company's common stock is listed under the ISIN CA0717051076 and is classified under the GICS Sub Industry of Health Care Equipment, reflecting its focus on developing and manufacturing medical devices and equipment for the eye care sector. With its diverse portfolio of products and services, Bausch + Lomb is well-positioned to address the evolving needs of the global eye health market and continue its legacy as a trusted and reliable partner for eye care professionals and patients alike.